Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral rsCT for Prevention of Postmenopausal Osteoporosis
NCT01292187Phase 2Completed
- Sponsor
- Tarsa Therapeutics, Inc.
- Start
- Jan 2011
- Primary completion
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of calcitonin salmon in osteoporosis, sponsored by Tarsa Therapeutics, Inc.. Started Jan 2011; status: completed.
02
Drugs
calcitonin salmon
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01292187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01292187.